Search research articles
Contact Us
Filters
Showing results (351-360 of 485) with videos related to
Page
of 49
Sort By:
BMC Health Services Research
|
November 14, 2018
Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan
Feras Darwish Elhajji, Ghaith M Al-Taani, Lana Anani, et al.
Tropical Medicine and Infectious Disease
|
May 27, 2022
Antimicrobial Prescribing Patterns in Patients with COVID-19 in Russian Multi-Field Hospitals in 2021: Results of the Global-PPS Project
Sergey Avdeev, Svetlana Rachina, Yuliya Belkova, et al.
Frontiers in Microbiology
|
July 30, 2014
Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus
Marta Canuti, Martin Deijs, Seyed M Jazaeri Farsani, et al.
ERJ Open Research
|
May 16, 2018
A trial like ALIC<sup>4</sup>E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Christopher C Butler, Samuel Coenen, Benjamin R Saville, et al.
Journal of Infection Prevention
|
February 23, 2023
Antimicrobial use among paediatric inpatients in a Nigerian tertiary hospital: A three-year point prevalence survey
Chukwuma D Umeokonkwo, Cosmas K Onah, Azuka S Adeke, et al.
Family Practice
|
June 6, 2015
Validity of a clinical model to predict influenza in patients presenting with symptoms of lower respiratory tract infection in primary care
Saskia F van Vugt, Berna Dl Broekhuizen, Nicolaas Pa Zuithoff, et al.
The European Respiratory Journal
|
August 29, 2020
Efficacy and safety of TOBI Podhaler in <i>Pseudomonas aeruginosa-</i>infected bronchiectasis patients: iBEST study
Michael R Loebinger, Eva Polverino, James D Chalmers, et al.
The Journal of Infectious Diseases
|
September 3, 2013
IFITM3 and susceptibility to respiratory viral infections in the community
Tara C Mills, Anna Rautanen, Katherine S Elliott, et al.
BMJ Open
|
September 19, 2022
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up
Niels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, et al.
Genome Medicine
|
December 20, 2024
Tracing carriage, acquisition, and transmission of ESBL-producing Escherichia coli over two years in a tertiary care hospital
Minh Ngoc Nguyen, Beryl Primrose Gladstone, Giulia De Angelis, et al.
Page
of 49
Search research articles
Search
Showing results (351-360 of 485) with videos related to
Sort By:
Page
of 49
BMC Health Services Research
|
November 14, 2018
Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan
Feras Darwish Elhajji, Ghaith M Al-Taani, Lana Anani, et al.
Tropical Medicine and Infectious Disease
|
May 27, 2022
Antimicrobial Prescribing Patterns in Patients with COVID-19 in Russian Multi-Field Hospitals in 2021: Results of the Global-PPS Project
Sergey Avdeev, Svetlana Rachina, Yuliya Belkova, et al.
Frontiers in Microbiology
|
July 30, 2014
Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus
Marta Canuti, Martin Deijs, Seyed M Jazaeri Farsani, et al.
ERJ Open Research
|
May 16, 2018
A trial like ALIC<sup>4</sup>E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Christopher C Butler, Samuel Coenen, Benjamin R Saville, et al.
Journal of Infection Prevention
|
February 23, 2023
Antimicrobial use among paediatric inpatients in a Nigerian tertiary hospital: A three-year point prevalence survey
Chukwuma D Umeokonkwo, Cosmas K Onah, Azuka S Adeke, et al.
Family Practice
|
June 6, 2015
Validity of a clinical model to predict influenza in patients presenting with symptoms of lower respiratory tract infection in primary care
Saskia F van Vugt, Berna Dl Broekhuizen, Nicolaas Pa Zuithoff, et al.
The European Respiratory Journal
|
August 29, 2020
Efficacy and safety of TOBI Podhaler in <i>Pseudomonas aeruginosa-</i>infected bronchiectasis patients: iBEST study
Michael R Loebinger, Eva Polverino, James D Chalmers, et al.
The Journal of Infectious Diseases
|
September 3, 2013
IFITM3 and susceptibility to respiratory viral infections in the community
Tara C Mills, Anna Rautanen, Katherine S Elliott, et al.
BMJ Open
|
September 19, 2022
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up
Niels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, et al.
Genome Medicine
|
December 20, 2024
Tracing carriage, acquisition, and transmission of ESBL-producing Escherichia coli over two years in a tertiary care hospital
Minh Ngoc Nguyen, Beryl Primrose Gladstone, Giulia De Angelis, et al.
Page
of 49